by mcwebmaster | Mar 7, 2019
Yonina Fleischman holds the position of ESG Access to Medicines Lead at Teva Pharmaceuticals. In her role, she leads Teva Access, a key component of Teva’s ESG strategy, whose mission is to bring sustainable solutions that expand access to Teva’s broad portfolio of...
by Danny O'Keefe | Jun 21, 2023
Neil Moorhouse heads Global Communications and ESG at Centrient, the Netherlands-based business-to-business leader in antibiotics, statins and antifungals. Neil has more than 25 years experience in communications and the media, holding a variety roles in different...
by Danny O'Keefe | Aug 8, 2024
James Headen Pfitzer joined Viatris as Senior Director Global Policy, Corporate Affairs in Geneva in September 2022. Prior to that, James spent five years leading the access to NCD treatments and health systems strengthening initiatives at IFPMA. Before that James...
by Luka Srot | Oct 23, 2020
Dr. Boumediene Soufi is a biotechnologist by training, specializing in the field of microbial quantitative proteomics. He holds the position of Global Head Antimicrobial Resistance at Sandoz, the largest provider of generic antibiotic medicines globally. The program...
by Danny O'Keefe | Feb 23, 2023
Matthias Tyssen joined Fresenius Kabi in 2014, currently heading portfolio and project management, product development, strategic marketing, regulatory and medical affairs as well as alliance management for the generic drug and I.V. fluids portfolio of outside of...
